Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plcverified

AVDL

Price:

$15.6

Market Cap:

$1.50B

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

1996-06-07

Stock Exchange

NASDAQ

Ticker

AVDL

The PE Ratio as of June 2024 (TTM) for Avadel Pharmaceuticals plc (AVDL) is -8.57

According to Avadel Pharmaceuticals plc’s latest financial reports and current stock price. The company's current PE Ratio is -8.57. This represents a change of -7.11% compared to the average of -9.23 of the last 4 quarters.

Avadel Pharmaceuticals plc (AVDL) Historical PE Ratio (quarterly & annually)

How has AVDL PE Ratio performed in the past?

The mean historical PE Ratio of Avadel Pharmaceuticals plc over the last ten years is 2.40. The current -8.57 PE Ratio has changed -35832.82% with respect to the historical average. Over the past ten years (40 quarters), AVDL's PE Ratio was at its highest in in the December 2016 quarter at 22.64. The PE Ratio was at its lowest in in the March 2020 quarter at -94.22.

Quarterly (TTM)
Annual

Average

2.40

Median

-4.62

Minimum

-10.38

Maximum

50.37

Avadel Pharmaceuticals plc (AVDL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Avadel Pharmaceuticals plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 741.14%

Maximum Annual PE Ratio = 50.37

Minimum Annual Increase = -692.67%

Minimum Annual PE Ratio = -10.38

Quarterly (TTM)
Annual
YearPE RatioChange
2023-7.06125.65%
2022-3.13-48.82%
2021-6.12-112.14%
202050.37-692.67%
2019-8.50741.14%
2018-1.01-120.48%
20174.93-147.52%
2016-10.38-185.20%
201512.19-266.79%
2014-7.3153.29%

Avadel Pharmaceuticals plc (AVDL) Average PE Ratio

How has AVDL PE Ratio performed in the past?

The current PE Ratio of Avadel Pharmaceuticals plc (AVDL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-5.44

5-year avg

5.11

10-year avg

2.40

Avadel Pharmaceuticals plc (AVDL) PE Ratio vs. Peers

How is AVDL’s PE Ratio compared to its peers?

Avadel Pharmaceuticals plc’s PE Ratio is less than Neurocrine Biosciences, Inc. (35.33), greater than Deciphera Pharmaceuticals, Inc. (-11.74), less than Ironwood Pharmaceuticals, Inc. (-0.85), less than Alkermes plc (9.44), greater than Intra-Cellular Therapies, Inc. (-65.95), less than Dynavax Technologies Corporation (159.26), greater than Journey Medical Corporation (-25.56), less than Evoke Pharma, Inc. (-0.64), less than Jupiter Wellness, Inc. (-3.87), less than Aquestive Therapeutics, Inc. (-6.86), less than Eagle Pharmaceuticals, Inc. (2.71), less than ANI Pharmaceuticals, Inc. (32.63), less than Agile Therapeutics, Inc. (-0.20), less than Assertio Holdings, Inc. (-0.31), greater than Amneal Pharmaceuticals, Inc. (-12.24), less than AcelRx Pharmaceuticals, Inc. (-1.83), less than Lifecore Biomedical, Inc. (-2.87),

Build a custom stock screener for Avadel Pharmaceuticals plc (AVDL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avadel Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avadel Pharmaceuticals plc (AVDL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avadel Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Avadel Pharmaceuticals plc's PE Ratio?

How is the PE Ratio calculated for Avadel Pharmaceuticals plc (AVDL)?

What is the highest PE Ratio for Avadel Pharmaceuticals plc (AVDL)?

What is the 3-year average PE Ratio for Avadel Pharmaceuticals plc (AVDL)?

What is the 5-year average PE Ratio for Avadel Pharmaceuticals plc (AVDL)?

How does the current PE Ratio for Avadel Pharmaceuticals plc (AVDL) compare to its historical average?